GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dawnrays Pharmaceutical (Holdings) Ltd (HKSE:02348) » Definitions » Forward Dividend Yield %

Dawnrays Pharmaceutical (Holdings) (HKSE:02348) Forward Dividend Yield % : 5.38% (As of May. 07, 2025)


View and export this data going back to 2003. Start your Free Trial

What is Dawnrays Pharmaceutical (Holdings) Forward Dividend Yield %?

As of today (2025-05-07), the Forward Annual Dividend Yield of Dawnrays Pharmaceutical (Holdings) is 5.38%.

As of today (2025-05-07), the Trailing Annual Dividend Yield of Dawnrays Pharmaceutical (Holdings) is 6.84%.

HKSE:02348's Forward Dividend Yield % is ranked better than
91.62% of 513 companies
in the Drug Manufacturers industry
Industry Median: 1.84 vs HKSE:02348: 5.38

Dawnrays Pharmaceutical (Holdings)'s Dividends per Share for the six months ended in Dec. 2024 was HK$0.01.

During the past 12 months, Dawnrays Pharmaceutical (Holdings)'s average Dividends Per Share Growth Rate was -10.30% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 5.70% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 30.70% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 4.10% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Dawnrays Pharmaceutical (Holdings) was 72.50% per year. The lowest was -40.40% per year. And the median was 10.10% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Dawnrays Pharmaceutical (Holdings)'s Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Dawnrays Pharmaceutical (Holdings)'s Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dawnrays Pharmaceutical (Holdings)'s Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dawnrays Pharmaceutical (Holdings)'s Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Dawnrays Pharmaceutical (Holdings)'s Forward Dividend Yield % falls into.


;
;

Dawnrays Pharmaceutical (Holdings) Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Dawnrays Pharmaceutical (Holdings) Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
HKD 0.0150002024-09-162024-09-182024-10-03Cash Dividendsemi-annuallyHKD:HKD 1.000000
HKD 0.0650002024-05-282024-05-302024-06-12Cash Dividendsemi-annuallyHKD:HKD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Dawnrays Pharmaceutical (Holdings)'s Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.03/1.17
=2.56 %

Current Share Price is HK$1.17.
Dawnrays Pharmaceutical (Holdings)'s Dividends per Share for the forward twelve months is calculated as HK$0.015 * 2 = HK$0.03.

Dawnrays Pharmaceutical (Holdings)'s Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.08/1.17
=6.84 %

Current Share Price is HK$1.17.
Dawnrays Pharmaceutical (Holdings)'s Dividends per Share for the trailing twelve months (TTM) ended in Today is HK$0.08.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dawnrays Pharmaceutical (Holdings)  (HKSE:02348) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Dawnrays Pharmaceutical (Holdings) Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Dawnrays Pharmaceutical (Holdings)'s Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dawnrays Pharmaceutical (Holdings) Business Description

Traded in Other Exchanges
N/A
Address
338 Hennessy Road, Units 3001-02, 30th Floor, CNT Tower, Wanchai, North Sea Centre, Hong Kong, HKG
Dawnrays Pharmaceutical (Holdings) Ltd is a drug manufacturing company. The company operates two segments, including Intermediates and Bulk Medicines, and Finished Drugs. The revenue is derived from the Finished Drugs segment. Nearly all of the company's sales are generated in Mainland China. It utilizes strategic partnerships as a component of its international strategies. The company is open to exploring potential acquisitions as a component of its overall growth plan.
Executives
Li Kei Ling
Hung Yung Lai
Fortune United Group Limited 2101 Beneficial owner
Hunwick International Limited 2201 Interest of corporation controlled by you
Keysmart Enterprises Limited 2201 Interest of corporation controlled by you
Iu Pun 2202 Interest of your spouse
Li Tung Ming
Fmr Llc 2201 Interest of corporation controlled by you
Toyo International Investment Limited
Leung Hong Man
Leung Yiu Sing
Chu Shuet Fong
Lo Mei Sai
Time Lead Investments Limited

Dawnrays Pharmaceutical (Holdings) Headlines

No Headlines